Skip Global navigation and goto content

It's a New Day in Public Health.

The Florida Department of Health works to protect, promote, and improve the health of all people in Florida through integrated state, county, and community efforts.

Skip MegaMenu and goto content
Megamenu requires javascript to be enabled in your browser.

Alzheimer’s Disease Research Grant Advisory Board

Contact: Florida Health

Alzheimer’s Disease Research Grant Advisory Board 

The Advisory Board, authorized in Section 381.82, Florida Statutes, advises the State Surgeon General as to the scope of the research program and shall submit its recommendations for proposals to be funded to the State Surgeon General by December 15 of each year. Grants and fellowships shall be awarded by the State Surgeon General, after consultation with the Advisory Board, on the basis of scientific merit. Other responsibilities of the Advisory Board may include, but are not limited to, providing advice on program priorities and emphases; assisting in the development of appropriate linkages to nonacademic entities, such as voluntary organizations, health care delivery institutions, industry, government agencies, and public officials; and developing and providing oversight regarding mechanisms for the dissemination of research results.

Annually the Alzheimer’s Disease Research Grant Advisory Board submits a fiscal-year progress report, including the following information as required by Florida Statute:

  1. A list of research projects supported by grants or fellowships awarded under the program.
  2. A list of recipients of program grants or fellowships.
  3. A list of publications in peer-reviewed journals involving research supported by grants or fellowships awarded under the program.
  4. The state ranking and total amount of Alzheimer’s disease research funding currently flowing into the state from the National Institutes of Health.
  5. New grants for Alzheimer’s disease research which were funded based on research supported by grants or fellowships awarded under the program.
  6. Progress toward programmatic goals, particularly in the prevention, diagnosis, treatment, and cure of Alzheimer’s disease.
  7. Recommendations to further the mission of the program.